Carnick & Kubik Group LLC acquired a new stake in Thermo Fisher Scientific Inc (NYSE:TMO) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 7,313 shares of the medical research company’s stock, valued at approximately $1,384,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Proficio Capital Partners LLC increased its holdings in shares of Thermo Fisher Scientific by 71.5% in the 1st quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after acquiring an additional 253 shares during the last quarter. Chicago Partners Investment Group LLC purchased a new position in shares of Thermo Fisher Scientific in the 2nd quarter valued at about $108,000. Cribstone Capital Management LLC increased its holdings in shares of Thermo Fisher Scientific by 8.7% in the 2nd quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after acquiring an additional 50 shares during the last quarter. Shine Investment Advisory Services Inc. purchased a new position in shares of Thermo Fisher Scientific in the 2nd quarter valued at about $113,000. Finally, CWM LLC increased its holdings in shares of Thermo Fisher Scientific by 17.0% in the 2nd quarter. CWM LLC now owns 710 shares of the medical research company’s stock valued at $124,000 after acquiring an additional 103 shares during the last quarter. Institutional investors and hedge funds own 83.78% of the company’s stock.

In other news, Director Jim P. Manzi sold 11,318 shares of the firm’s stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $172.94, for a total value of $1,957,334.92. Following the completion of the sale, the director now directly owns 38,757 shares of the company’s stock, valued at approximately $6,702,635.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Seth H. Hoogasian sold 4,140 shares of the firm’s stock in a transaction that occurred on Monday, August 28th. The shares were sold at an average price of $177.80, for a total value of $736,092.00. Following the completion of the sale, the vice president now directly owns 25,518 shares of the company’s stock, valued at $4,537,100.40. The disclosure for this sale can be found here. Insiders have sold a total of 21,738 shares of company stock valued at $3,846,312 over the last ninety days. 0.49% of the stock is owned by insiders.

Shares of Thermo Fisher Scientific Inc (TMO) opened at $188.51 on Thursday. Thermo Fisher Scientific Inc has a 1 year low of $139.07 and a 1 year high of $201.20. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26. The firm has a market capitalization of $75,820.21, a P/E ratio of 20.78, a price-to-earnings-growth ratio of 1.73 and a beta of 1.08.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The company had revenue of $5.12 billion during the quarter, compared to analysts’ expectations of $5.03 billion. During the same period last year, the firm earned $2.03 EPS. The firm’s revenue for the quarter was up 13.9% on a year-over-year basis. equities analysts predict that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.32%. Thermo Fisher Scientific’s payout ratio is 10.19%.

WARNING: This article was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.watchlistnews.com/carnick-kubik-group-llc-invests-1-38-million-in-thermo-fisher-scientific-inc-tmo/1706573.html.

TMO has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $214.00 price objective on the stock in a report on Thursday, September 14th. Bank of America Corporation reiterated a “buy” rating and issued a $210.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Friday, July 21st. Cleveland Research upgraded Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a report on Thursday, July 20th. Cowen and Company reiterated a “buy” rating and issued a $200.00 price objective on shares of Thermo Fisher Scientific in a report on Friday, September 1st. Finally, Argus reiterated a “buy” rating on shares of Thermo Fisher Scientific in a report on Tuesday, August 22nd. They noted that the move was a valuation call. One investment analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $205.71.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.